Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Remdesivir  COVID-19 treatment studies for Remdesivir  C19 studies: Remdesivir  Remdesivir   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality -1612% Improvement Relative Risk c19early.org/s Kim et al. Remdesivir for COVID-19 LATE TREATMENT Is late treatment with remdesivir beneficial for COVID-19? Retrospective 167 patients in South Korea (November 2021 - April 2022) Higher mortality with remdesivir (not stat. sig., p=0.22) Kim et al., J. Clinical Medicine, doi:10.3390/jcm12062279 Favors remdesivir Favors control

Clinical Outcome and Prognosis of a Nosocomial Outbreak of COVID-19

Kim et al., Journal of Clinical Medicine, doi:10.3390/jcm12062279
Kim et al., Clinical Outcome and Prognosis of a Nosocomial Outbreak of COVID-19, Journal of Clinical Medicine, doi:10.3390/jcm12062279
Mar 2023   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 167 nosocomial COVID-19 patients in South Korea, showing higher mortality with remdesivir treatment, without statistical significance.
[Gérard, Wu, Zhou] show significantly increased risk of acute kidney injury with remdesivir.
risk of death, 1612.4% higher, RR 17.12, p = 0.22, treatment 14 of 145 (9.7%), control 0 of 22 (0.0%), continuity correction due to zero event (with reciprocal of the contrasting arm).
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Kim et al., 15 Mar 2023, retrospective, South Korea, peer-reviewed, 5 authors, study period 1 November, 2021 - 30 April, 2022.
Contact: sysliver@naver.com (corresponding author).
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperRemdesivirAll
Clinical Outcome and Prognosis of a Nosocomial Outbreak of COVID-19
Sang Hyuk Kim, Taehee Kim, Hayoung Choi, Tae Rim Shin, Yun Su Sim
Journal of Clinical Medicine, doi:10.3390/jcm12062279
Nosocomial coronavirus disease 2019 (COVID-19) outbreaks have been reported despite widespread quarantine methods to prevent COVID-19 in society and hospitals. Our study was performed to investigate the clinical outcome and prognosis of a nosocomial outbreak of COVID-19. We retrospectively analyzed the medical records of patients diagnosed with nosocomial COVID-19 of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at a university teaching hospital between 1 November 2021 and 31 April 2022. Nosocomial COVID-19 was defined as a positive SARS-CoV-2 polymerase chain reaction (PCR) test result 4 or more days after admission in asymptomatic patients who had a negative SARS-CoV-2 PCR test on admission. In this study, 167 patients were diagnosed with nosocomial COVID-19 (1.14%) among a total of 14,667 patients admitted to hospital during the study period. A total of 153 patients (91.6%) survived, but 14 patients (8.4%) died. The median time between admission and COVID-19 diagnosis was 11 days, and the median duration of hospital stay was 24 days. After adjusting for other factors, no vaccination (adjusted HR = 5.944, 95% CI = 1.626-21.733, p = 0.007) and chronic kidney disease (adjusted HR = 6.963, 95% CI = 1.182-41.014, p = 0.032) were found to increase mortality risk. Despite strict quarantine, a significant number of nosocomial COVID-19 cases with a relatively high mortality rate were reported. As unvaccinated status or chronic kidney disease were associated with poor outcomes of nosocomial COVID-19, more active preventive strategies and treatments for patients with these risk factors are needed.
Informed Consent Statement: Informed consent was waived due to the retrospective nature of the study. Conflicts of Interest: The authors declare no conflict of interest.
References
Baden, El Sahly, Essink, Kotloff, Frey et al., Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine, N. Engl. J. Med, doi:10.1056/NEJMoa2035389
Biernat, Zi Ńczuk, Biernat, Bogucka-Fedorczuk, Kwiatkowski et al., Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit-High mortality rate in infected patients with haematologic malignancies, J. Clin. Virol, doi:10.1016/j.jcv.2020.104574
Blackstone, Stirrup, Mapp, Panca, Copas et al., Protocol for the COG-UK hospital-onset COVID-19 infection (HOCI) multicentre interventional clinical study: Evaluating the efficacy of rapid genome sequencing of SARS-CoV-2 in limiting the spread of COVID-19 in UK NHS hospitals, BMJ Open
Borges, Isidro, Macedo, Neves, Silva et al., Nosocomial Outbreak of SARS-CoV-2 in a "Non-COVID-19" Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission, Viruses, doi:10.3390/v13040604
Boshier, Venturini, Stirrup, Guerra-Assunção, Alcolea-Medina et al., The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study, J. Infect, doi:10.1016/j.jinf.2021.09.022
Carter, Collins, Barlow-Pay, Rickard, Bruce et al., Nosocomial COVID-19 infection: Examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople), J. Hosp. Infect, doi:10.1016/j.jhin.2020.07.013
Choi, COVID-19 in South Korea, Postgrad Med. J, doi:10.1136/postgradmedj-2020-137738
Eckart, Hauser, Kutz, Haubitz, Hausfater et al., Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: Results of a multinational, observational study, BMJ Open, doi:10.1136/bmjopen-2018-024636
Guan, Ni, Hu, Liang, Qu et al., Clinical Characteristics of coronavirus disease 2019 in China, N. Engl. J. Med, doi:10.1056/NEJMoa2002032
Hawkins, Pallett, Mazzella, Anton-Vazquez, Rosas et al., Transmission dynamics and associated mortality of nosocomial COVID-19 throughout 2021: A retrospective study at a large teaching hospital in London, J. Hosp. Infect, doi:10.1016/j.jhin.2022.12.014
Itoh, Akazawa, Ishikane, Kawabata, Kawamura et al., Lessons learned from an outbreak of COVID-19 in the head and neck surgery ward of a Japanese cancer center during the sixth wave by Omicron, J. Infect. Chemother, doi:10.1016/j.jiac.2022.08.010
Jang, Kim, Kim, Song, Moon et al., Are the Current Guidelines Sufficient to Establish Infection Control Strategies for COVID-19 Related Issues in Hospitals?, J. Korean Med. Sci, doi:10.3346/jkms.2021.36.e343
Jang, Kim, Moon, Kim, Lee, Correlation Between Third Dose of COVID-19 Vaccines and Regional Case Fatality Rates During the Omicron Wave in Korea, J. Korean Med. Sci, doi:10.3346/jkms.2022.37.e347
Jia, Gong, Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?, J. Korean Med. Sci, doi:10.3346/jkms.2021.36.e124
Jia, Li, Li, Hou, Ma et al., Impact of Healthcare-Associated Infections on Length of Stay: A Study in 68 Hospitals in China, BioMed. Res. Int, doi:10.1155/2019/2590563
Jung, Lee, Park, Lim, Kim et al., Nosocomial Outbreak by Delta Variant from a Fully Vaccinated Patient, J. Korean Med. Sci, doi:10.3346/jkms.2022.37.e133
Kim, Choi, Jin, Choi, Lee et al., Predicting severe outcomes using national early warning score (NEWS) in patients identified by a rapid response system: A retrospective cohort study, Sci. Rep, doi:10.1038/s41598-021-97121-w
Kim, Kang, Lim, Lee, Kang et al., Comprehensive risk assessment for hospital-acquired pneumonia: Sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia, BMC Pulm. Med, doi:10.1186/s12890-021-01816-9
Klompas, Pandolfi, Nisar, Baker, Rhee, Association of Omicron vs Wild-type SARS-CoV-2 Variants with Hospital-Onset SARS-CoV-2 Infections in a US Regional Hospital System, JAMA, doi:10.1001/jama.2022.9609
Kumar, Thambiraja, Karuppanan, Subramaniam, Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein, J. Med. Virol, doi:10.1002/jmv.27526
Kwon, Oh, COVID-19 vaccination program in South Korea: A long journey toward a new normal, Health Policy Technol, doi:10.1016/j.hlpt.2022.100601
Leducq, Couturier, Granger, Jolivet, Morand-Joubert et al., Investigation of healthcare-associated COVID-19 in a large French hospital group by whole-genome sequencing, Microbiol. Res, doi:10.1016/j.micres.2022.127133
Lee, Lee, Park, Choe, Song et al., Breakthrough COVID-19 Infection during the Delta Variant Dominant Period: Individualized Care Based on Vaccination Status Is Needed, J. Korean Med. Sci, doi:10.3346/jkms.2022.37.e252
Li, Peng, Li, Wang, Ping et al., Clinical and Transmission Characteristics of COVID-19-A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department, Curr. Med. Sci
Luong-Nguyen, Hermand, Abdalla, Cabrit, Hobeika et al., Nosocomial infection with SARS-CoV-2 within Departments of Digestive Surgery, J. Visc. Surg, doi:10.1016/j.jviscsurg.2020.04.016
Meister, Pisarev, Kolde, Kalda, Suija et al., Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia, PLoS ONE, doi:10.1371/journal.pone.0270192
Nomura, Eguchi, Yoneoka, Kawashima, Tanoue et al., Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A large cross-sectional national survey, Lancet Reg. Health West. Pac, doi:10.1016/j.lanwpc.2021.100223
Nyberg, Ferguson, Nash, Webster, Flaxman et al., Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron, Lancet, doi:10.1016/S0140-6736(22)00462-7
Paltansing, Sikkema, De Man, Koopmans, Munnink et al., Transmission of SARS-CoV-2 among healthcare workers and patients in a teaching hospital in The Netherlands confirmed by whole-genome sequencing, J. Hosp. Infect, doi:10.1016/j.jhin.2021.02.005
Ponsford, Jefferies, Davies, Farewell, Humphreys et al., Burden of nosocomial COVID-19 in Wales: Results from a multicentre retrospective observational study of 2508 hospitalised adults, Thorax, doi:10.1136/thoraxjnl-2021-216964
Rockett, Arnott, Lam, Sadsad, Timms et al., Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling, Nat. Med, doi:10.1038/s41591-020-1000-7
Shi, Lee, Kang, Choi, Eom, Importance of Wearing Facial Masks to Prevent Nosocomial Transmissions of COVID-19, Korean J. Health Infect. Control. Prev, doi:10.14192/kjicp.2021.26.2.101
Sohn, Shin, Oh, Kim, Kim et al., Clinical Characteristics of Patients Who Contracted the SARS-CoV-2 Omicron Variant from an Outbreak in a Single Hospital, Yonsei Med. J, doi:10.3349/ymj.2022.63.8.790
Syed-Ahmed, Narayanan, Immune Dysfunction and Risk of Infection in Chronic Kidney Disease, Adv. Chronic Kidney Dis, doi:10.1053/j.ackd.2019.01.004
Thomas, Suresh, Assessment of COVID-19 prevention and protection measures in hospitals, Clean. Eng. Technol, doi:10.1016/j.clet.2022.100440
Wong, Chan, Yuen, Auyeung, Leung et al., Infection of healthcare workers despite a high vaccination rate during the fifth wave of COVID-19 due to Omicron variant in Hong Kong, Infect. Prev. Pr, doi:10.1016/j.infpip.2022.100261
Zhang, Xiao, Deng, Zhang, Zhuang et al., Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2-Guangdong Province, China, China CDC Wkly, doi:10.46234/ccdcw2021.148
Zhou, Gao, Wang, Liu, Du et al., Nosocomial infections among patients with COVID-19, SARS and MERS: A rapid review and meta-analysis, Ann. Transl. Med, doi:10.21037/atm-20-3324
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit